These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2881326)

  • 1. Pharmacology and biochemistry of neurotensin receptors.
    Kitabgi P; Checler F; Mazella J; Vincent JP
    Rev Clin Basic Pharm; 1985; 5(3-4):397-486. PubMed ID: 2881326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurotensin].
    Wang W; Chen YJ
    Sheng Li Ke Xue Jin Zhan; 1985 Oct; 16(4):312-6. PubMed ID: 2874608
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neurotensin: physiological properties and role in the regulation of organism function].
    Osadchiĭ OE
    Usp Fiziol Nauk; 2004; 35(2):3-21. PubMed ID: 15174292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotensin--structure, origin and biological function].
    Kulińska-Niedziela I; Paluszak J
    Postepy Hig Med Dosw; 1997; 51(3):329-42. PubMed ID: 9333784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurotensin/dopamine interactions].
    Kitabgi P; Hervé D; Studler JM; Tramu G; Rostène W; Tassin JP
    Encephale; 1989; 15 Spec No():91-4. PubMed ID: 2545433
    [No Abstract]   [Full Text] [Related]  

  • 6. Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the rat.
    Agnati LF; Fuxe K; Battistini N; Giardino L; Benfenati F; Martire M; Ruggeri M
    Acta Physiol Scand; 1985 May; 124(1):125-8. PubMed ID: 2990164
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.
    García-Garayoa E; Maes V; Bläuenstein P; Blanc A; Hohn A; Tourwé D; Schubiger PA
    Nucl Med Biol; 2006 May; 33(4):495-503. PubMed ID: 16720241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioligand-binding assays for study of neurotensin receptors.
    Goedert M
    Methods Enzymol; 1989; 168():462-81. PubMed ID: 2542730
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
    Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
    J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13).
    Donato di Paola E; Cusack B; Yamada M; Richelson E
    J Pharmacol Exp Ther; 1993 Jan; 264(1):1-5. PubMed ID: 8380855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on neurotensin as a hormone. Assay and release of neurotensin-like immunoreactivity and effects of neurotensin.
    Rökaeus A
    Acta Physiol Scand Suppl; 1981; 501():1-62. PubMed ID: 6954834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Localization and physiologic role of neurotensin and its receptor].
    Kito S; Miyoshi R
    Nihon Rinsho; 1990 May; 48(5):999-1004. PubMed ID: 1973961
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of neurotensin on the cardiovascular system].
    Osadchiĭ OE; Pokrovskiĭ VM
    Usp Fiziol Nauk; 1998; 29(2):39-54. PubMed ID: 9659683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.
    Kitabgi P
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):764-76. PubMed ID: 12630297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin and the mesocorticolimbic dopamine system.
    Bissette G; Nemeroff CB
    Ann N Y Acad Sci; 1988; 537():397-404. PubMed ID: 2849357
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preparation of iodinated standards for quantitative radioautography in vitro using a tritium-sensitive film].
    Rostène W; Mourre C
    C R Acad Sci III; 1985; 301(5):245-50. PubMed ID: 2998569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation.
    Zhao D; Pothoulakis C
    Peptides; 2006 Oct; 27(10):2434-44. PubMed ID: 16872719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and biological activity of cyclic and linear analogs of C-terminal fragments of neurotensin].
    Grinshteĭne IV; Misinia IP; Vegner RE; Vosekalna IA; Gaĭlite EA
    Bioorg Khim; 1985 Sep; 11(9):1167-79. PubMed ID: 4062994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.
    Dumont Y; Martel JC; Fournier A; St-Pierre S; Quirion R
    Prog Neurobiol; 1992; 38(2):125-67. PubMed ID: 1312243
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular mechanisms for neurotensin receptor-mediated release of prolactin.
    Memo M; Castelletti L; Valerio A; Pizzi M; Missale C; Carruba MO; Spano PF
    Regul Pept Suppl; 1985; 4():200-2. PubMed ID: 2997852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.